Biliary Decompression in Perihilar Cholangiocarcinoma Improves Survival: A Single-Center Retrospective Analysis.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
02 2019
Historique:
received: 13 03 2018
accepted: 04 09 2018
pubmed: 22 9 2018
medline: 26 3 2019
entrez: 22 9 2018
Statut: ppublish

Résumé

The complex biliary strictures of perihilar cholangiocarcinoma present significant challenges for providing adequate and long-lasting biliary drainage. The best approach to relieve obstruction remains controversial. The purpose of this study was to assess stenting outcomes in perihilar cholangiocarcinoma. This study was approved by the center's institutional review board. Subjects with a diagnosis of perihilar cholangiocarcinoma who underwent endoscopic retrograde cholangiopancreatography (ERCP) were identified from endoscopic and pathologic databases from 1997 to 2014. Patient characteristics, endoscopic data, and follow-up evaluation data were retrospectively collected via review of available medical records. A total of 199 patients with perihilar cholangiocarcinoma who underwent a total of 504 ERCPs were included in the study. Nine of 504 (1.8%) procedures were technical failures. Among the 495 technically successful procedures, 347 (70.1%) procedures were clinical successes. Clinical success was significantly associated with longer overall survival (HR 0.57; p = 0.002). A higher proportion of patients with bilateral drainage had clinical success, compared with those with unilateral drainage. Cholangitis was not more common in the bilateral group compared to the unilateral group except in the group where a segment was not drained (1.9% vs 1.6% vs 7.1%, respectively). Patients with metal stents were 3.8 times more likely to have clinical success than those with plastic stents. In conclusion, adequate biliary drainage improves overall survival. Bilateral stenting if anatomy permits with self-expanding metal stents rather than plastic stents appears to provide the optimal chance of clinical success.

Sections du résumé

BACKGROUND AND AIMS
The complex biliary strictures of perihilar cholangiocarcinoma present significant challenges for providing adequate and long-lasting biliary drainage. The best approach to relieve obstruction remains controversial. The purpose of this study was to assess stenting outcomes in perihilar cholangiocarcinoma.
METHODS
This study was approved by the center's institutional review board. Subjects with a diagnosis of perihilar cholangiocarcinoma who underwent endoscopic retrograde cholangiopancreatography (ERCP) were identified from endoscopic and pathologic databases from 1997 to 2014. Patient characteristics, endoscopic data, and follow-up evaluation data were retrospectively collected via review of available medical records.
RESULTS
A total of 199 patients with perihilar cholangiocarcinoma who underwent a total of 504 ERCPs were included in the study. Nine of 504 (1.8%) procedures were technical failures. Among the 495 technically successful procedures, 347 (70.1%) procedures were clinical successes. Clinical success was significantly associated with longer overall survival (HR 0.57; p = 0.002). A higher proportion of patients with bilateral drainage had clinical success, compared with those with unilateral drainage. Cholangitis was not more common in the bilateral group compared to the unilateral group except in the group where a segment was not drained (1.9% vs 1.6% vs 7.1%, respectively). Patients with metal stents were 3.8 times more likely to have clinical success than those with plastic stents.
CONCLUSIONS
In conclusion, adequate biliary drainage improves overall survival. Bilateral stenting if anatomy permits with self-expanding metal stents rather than plastic stents appears to provide the optimal chance of clinical success.

Identifiants

pubmed: 30238201
doi: 10.1007/s10620-018-5277-z
pii: 10.1007/s10620-018-5277-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-569

Commentaires et corrections

Type : CommentIn

Références

Gastrointest Endosc. 2012 Jul;76(1):93-9
pubmed: 22595446
Ann Surg. 2007 May;245(5):755-62
pubmed: 17457168
Gastrointest Endosc. 2010 Oct;72(4):728-35
pubmed: 20883850
Gastrointest Endosc. 1998 May;47(5):354-62
pubmed: 9609426
Gastrointest Endosc. 2001 May;53(6):547-53
pubmed: 11323577
Gastrointest Endosc. 2009 Jan;69(1):55-62
pubmed: 18657806
Gastroenterology. 2012 Jul;143(1):88-98.e3; quiz e14
pubmed: 22504095
BMC Gastroenterol. 2012 Aug 09;12:103
pubmed: 22873816
N Engl J Med. 2010 Apr 8;362(14):1273-81
pubmed: 20375404
Ann Surg. 2013 Jul;258(1):129-40
pubmed: 23059502
Hepatogastroenterology. 2006 Jan-Feb;53(67):21-7
pubmed: 16506370

Auteurs

Lisa S Cassani (LS)

Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. lisa.cassani@emory.edu.
Division of Digestive Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. lisa.cassani@emory.edu.
Division of Digestive Diseases, Department of Medicine, Atlanta Veterans Affairs Medical Center, Decatur, GA, USA. lisa.cassani@emory.edu.

Jay Chouhan (J)

Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Christopher Chan (C)

Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Gandhi Lanke (G)

Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hsiang-Chun Chen (HC)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Xuemei Wang (X)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Brian Weston (B)

Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

William A Ross (WA)

Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Gottumukkala S Raju (GS)

Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Jeffrey H Lee (JH)

Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH